Definium's LSD-based anxiety, depression drug scores another trial win
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Definium's LSD-based anxiety, depression drug scores another trial win" is generating significant coverage in the Business category, with 4 articles from 4 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Fierce Biotech, Pharmaceutical Technology, New Scientist and Yahoo Finance. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 1h ago.
Quick answers
Why is "Definium's LSD-based anxiety, depression drug scores another trial win" trending?
Because 4 independent news sources published 4 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (4)
- Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win Fierce Biotech · 2d ago
- Definium tees up regulatory submission for psychedelic on Phase III hat trick Pharmaceutical Technology · 2d ago
- LSD could be approved for anxiety in the US in 2027 New Scientist · 2d ago
- Definium Therapeutics (DFTX) Stock May Trade At A Premium Despite Phase 3 DT120 Results Yahoo Finance · 2d ago
Topics
Related trends
Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO says
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.